Jonathan E. Campbell

A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents

Brian Finan, Bin Yang, Nickki Ottaway et al. · Nature Medicine · 2014 · 609 citations · Full text

Obesity, Metabolic Syndrome, Neuropeptides +11

GLP-1 Receptor Activation Indirectly Reduces Hepatic Lipid Accumulation But Does Not Attenuate Development of Atherosclerosis in Diabetic Male ApoE−/− Mice

Naim Panjwani, Erin E. Mulvihill, Christine Longuet et al. · Endocrinology · 2012 · 338 citations · Full text

Fatty Liver Disease, Inflammation, Metabolic Syndrome +20

Adipogenic and lipolytic effects of chronic glucocorticoid exposure

Jonathan E. Campbell, Ashley J. Peckett, Anna M. D'souza et al. · American Journal of Physiology-Cell Physiology · 2010 · 220 citations

Visceral Adipose Tissue, Metabolic Disorder, Glucocorticoid +23

Effect of voluntary wheel running on circadian corticosterone release and on HPA axis responsiveness to restraint stress in Sprague-Dawley rats

Sergiu Fediuc, Jonathan E. Campbell, Michael C. Riddell · Journal of Applied Physiology · 2006 · 145 citations

Homeostatic Mechanism, Motor Control, Glucocorticoid +23

TCF1 links GIPR signaling to the control of beta cell function and survival

Jonathan E. Campbell, John R. Ussher, Erin E. Mulvihill et al. · Nature Medicine · 2015 · 145 citations

Molecular Physiology, Signal Transduction, Signaling Pathway +10